SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
HARVARD BIOSCIENCE
(NQNM:HBIO Last Sale: 2.45 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (HBIO : $2.45)
$93,952 million Market Cap at Market Close, July 1, 2022
Employs 400.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
84 October Hill Road Research Report Earnings Snapshot - Last 10/30/18
Holliston, MA 01746 Fact Sheet
Phone: (508) 893-8999 Financial Statements
Fax: (508) 429-5732 Peer Comparison
Annual Reports

Chane Graziano, CEO, David Green, Pres.
Develops and manufactures tools used in drug discovery research IPO at $8 December 6, 2000. Raised $51.4 million, selling 6.4 million shares, 26% of the outstanding. Lead Manager: Thomas Weisel Partners LLC. Acquired GENOMIC SOLUTIONS INC (Nasdaq:GNSL) October 24, 2002 for 2.3 million shares, issuing 0.1017 HBIO per GNSL and $0.29 cash.
Historical Charts    Technical Analysis
No Historical Data available for HBIO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common HBIO $2.45 $2.45 0 .0 $2.43 $2.6 153,582 $2.43 $2.6 38,347,658
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $93,951,762

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex